Angeles AK, Heckmann D, Flosdorf N et al (2020) The ERG-regulated LINC00920 promotes prostate cancer cell survival via the 14–3-3ε-FOXO pathway. Mol Cancer Res 18:1545–1559. https://doi.org/10.1158/1541-7786.Mcr-20-0021
Article CAS PubMed Google Scholar
Barbieri I, Kouzarides T (2020) Role of RNA modifications in cancer. Nat Rev Cancer 20:303–322. https://doi.org/10.1038/s41568-020-0253-2
Article CAS PubMed Google Scholar
Carrillo-Reixach J, Torrens L, Simon-Coma M et al (2020) Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J Hepatol 73:328–341. https://doi.org/10.1016/j.jhep.2020.03.025
Article CAS PubMed Google Scholar
Chen M, Wei L, Law CT et al (2018) RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology 67:2254–2270. https://doi.org/10.1002/hep.29683
Article CAS PubMed Google Scholar
de Winter JC, Gosling SD (2016) Potter J Comparing the Pearson and Spearman correlation coefficients across distributions and sample sizes: a tutorial using simulations and empirical data. Psychol Methods 21:273–90. https://doi.org/10.1037/met0000079
Dominissini D, Moshitch-Moshkovitz S, Schwartz S et al (2012) Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485:201–206. https://doi.org/10.1038/nature11112
Article CAS PubMed Google Scholar
Feng ZH, Liang YP, Cen JJ et al (2022) m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer. J Transl Med 20:492. https://doi.org/10.1186/s12967-022-03711-1
Article CAS PubMed PubMed Central Google Scholar
Fisher RA (1922) On the interpretation of χ2 from contingency tables, and the calculation of P. J R Stat Soc 85:87–94. https://doi.org/10.2307/2340521
Guo S, Zhang Y, Wang S et al (2021) LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling. Toxicol Lett 348:50–58. https://doi.org/10.1016/j.toxlet.2021.05.006
Article CAS PubMed Google Scholar
Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31–46. https://doi.org/10.1158/2159-8290.Cd-21-1059
Article CAS PubMed Google Scholar
Hänzelmann S, Castelo R, Guinney JGSVA (2013) gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7. https://doi.org/10.1186/1471-2105-14-7
Article PubMed PubMed Central Google Scholar
Ho KH, Shih CM, Liu AJ et al (2022) Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy. Cancer Sci 113:540–552. https://doi.org/10.1111/cas.15240
Article CAS PubMed Google Scholar
Hu X, Peng WX, Zhou H et al (2020) IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader. Cell Death Differ 27:1782–1794. https://doi.org/10.1038/s41418-019-0461-z
Article CAS PubMed Google Scholar
Hu XL, Huang XT, Zhang JN et al (2022) Long noncoding RNA MIR210HG is induced by hypoxia-inducible factor 1α and promotes cervical cancer progression. Am J Cancer Res 12:2783–2797
CAS PubMed PubMed Central Google Scholar
Hu D, Cao Q, Tong M et al (2022) A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer. BMC Med Genomics 15:24. https://doi.org/10.1186/s12920-022-01172-5
Article CAS PubMed PubMed Central Google Scholar
Kato H, Ichinose Y, Ohta M et al (2004) A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350:1713–1721. https://doi.org/10.1056/NEJMoa032792
Article CAS PubMed Google Scholar
Khaliq M, Manikkam M, Martinez ED et al (2021) Epigenetic modulation reveals differentiation state specificity of oncogene addiction. Nat Commun 12:1536. https://doi.org/10.1038/s41467-021-21784-2
Article CAS PubMed PubMed Central Google Scholar
Kundaje A, Meuleman W, Ernst J et al (2015) Integrative analysis of 111 reference human epigenomes. Nature 518:317–30. https://doi.org/10.1038/nature14248
Article CAS PubMed PubMed Central Google Scholar
Lang C, Yin C, Lin K et al (2021) m(6) A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Transl Med 11:e426. https://doi.org/10.1002/ctm2.426
Article CAS PubMed PubMed Central Google Scholar
Li R, Zhu J, Zhong W-D et al (2021) PCaDB - a comprehensive and interactive database for transcriptomes from prostate cancer population cohorts. bioRxiv. https://doi.org/10.1101/2021.06.29.449134
Article PubMed PubMed Central Google Scholar
Li B, Zhao R, Qiu W et al (2022) The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. Theranostics 12:6363–6379. https://doi.org/10.7150/thno.74600
Article CAS PubMed PubMed Central Google Scholar
Li C, Pan B, Wang X et al (2022) Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis. J Cancer Res Clin Oncol 148:1965–1982. https://doi.org/10.1007/s00432-022-03981-8
Article CAS PubMed Google Scholar
Li R, Zhu J, Zhong WD et al (2022) Comprehensive evaluation of machine learning models and gene expression signatures for prostate cancer prognosis using large population cohorts. Cancer Res 82:1832–1843. https://doi.org/10.1158/0008-5472.Can-21-3074
Article CAS PubMed Google Scholar
Liberzon A, Birger C, Thorvaldsdóttir H et al (2015) The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1:417–425. https://doi.org/10.1016/j.cels.2015.12.004
Article CAS PubMed PubMed Central Google Scholar
Liu J, Dou X, Chen C et al (2020) N (6)-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science 367:580–586. https://doi.org/10.1126/science.aay6018
Article CAS PubMed PubMed Central Google Scholar
Liu Z, Gao L, Cheng L et al (2023) The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications. Exp Mol Med. https://doi.org/10.1038/s12276-023-00944-y
Article PubMed PubMed Central Google Scholar
Lu J, Chen J, Lin Z et al (2023) A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer. Transl Oncol 33:101670. https://doi.org/10.1016/j.tranon.2023.101670
Article CAS PubMed PubMed Central Google Scholar
Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 18:50–60
Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–629. https://doi.org/10.1016/j.eururo.2016.08.003
Pei H, Dai Y, Yu Y et al (2023) The tumorigenic effect of lncRNA AFAP1-AS1 is mediated by translated peptide ATMLP under the control of m(6) A methylation. Adv Sci 10:e2300314. https://doi.org/10.1002/advs.202300314
Porman AM, Roberts JT, Duncan ED et al (2022) A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells. PLoS Biol 20:e3001885. https://doi.org/10.1371/journal.pbio.3001885
Article CAS PubMed PubMed Central Google Scholar
Raj A, van den Bogaard P, Rifkin SA et al (2008) Imaging individual mRNA molecules using multiple singly labeled probes. Nat Methods 5:877–9. https://doi.org/10.1038/nmeth.1253
Article CAS PubMed PubMed Central Google Scholar
Ritchie ME, Phipson B, Wu D et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. https://doi.org/10.1093/nar/gkv007
Article CAS PubMed PubMed Central Google Scholar
Roundtree IA, Evans ME, Pan T et al (2017) Dynamic RNA modifications in gene expression regulation. Cell 169:1187–1200. https://doi.org/10.1016/j.cell.2017.05.045
留言 (0)